These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
201 related items for PubMed ID: 7909438
1. Reduction of erbB2 gene product in mamma carcinoma cell lines by erbB2 mRNA-specific and tyrosine kinase consensus phosphorothioate antisense oligonucleotides. Bertram J, Killian M, Brysch W, Schlingensiepen KH, Kneba M. Biochem Biophys Res Commun; 1994 Apr 15; 200(1):661-7. PubMed ID: 7909438 [Abstract] [Full Text] [Related]
2. Inhibition of p185c-erbB-2 proto-oncogene expression by antisense oligodeoxynucleotides down-regulates p185-associated tyrosine-kinase activity and strongly inhibits mammary tumor-cell proliferation. Brysch W, Magal E, Louis JC, Kunst M, Klinger I, Schlingensiepen R, Schlingensiepen KH. Cancer Gene Ther; 1994 Jun 15; 1(2):99-105. PubMed ID: 7621247 [Abstract] [Full Text] [Related]
11. Altered gene expression in drug-resistant human breast cancer cells. Wosikowski K, Schuurhuis D, Kops GJ, Saceda M, Bates SE. Clin Cancer Res; 1997 Dec 02; 3(12 Pt 1):2405-14. PubMed ID: 9815641 [Abstract] [Full Text] [Related]
12. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts. Ramachandran C, Wellham LL. Anticancer Res; 2003 Dec 02; 23(3B):2681-90. PubMed ID: 12894558 [Abstract] [Full Text] [Related]
13. Antisense ferritin oligonucleotides inhibit growth and induce apoptosis in human breast carcinoma cells. Yang DC, Jiang X, Elliott RL, Head JF. Anticancer Res; 2002 Dec 02; 22(3):1513-24. PubMed ID: 12168831 [Abstract] [Full Text] [Related]
16. [The study of relationship between c-erbB2 expression and cytoimmunology in ovarian carcinoma and its antisense regulation]. Jin Z, Zhang X, Feng Y. Zhonghua Fu Chan Ke Za Zhi; 1995 Apr 02; 30(4):222-4. PubMed ID: 7664609 [Abstract] [Full Text] [Related]
17. Expression of the c-erbB2 gene in the BT474 human mammary tumor cell line: measurement of c-erbB2 mRNA half-life. Pasleau F, Grooteclaes M, Gol-Winkler R. Oncogene; 1993 Apr 02; 8(4):849-54. PubMed ID: 8096075 [Abstract] [Full Text] [Related]
18. Selective inhibition of A-Raf and C-Raf mRNA expression by antisense oligodeoxynucleotides in rat vascular smooth muscle cells: role of A-Raf and C-Raf in serum-induced proliferation. Cioffi CL, Garay M, Johnston JF, McGraw K, Boggs RT, Hreniuk D, Monia BP. Mol Pharmacol; 1997 Mar 02; 51(3):383-9. PubMed ID: 9058592 [Abstract] [Full Text] [Related]
19. Inhibition of TF gene expression by antisense oligonucleotides in different cancer cell lines. Förster Y, Schwenzer B. J Exp Ther Oncol; 2004 Dec 02; 4(4):281-9. PubMed ID: 15844658 [Abstract] [Full Text] [Related]
20. In vitro and in vivo reversal of multidrug resistance in a human leukemia-resistant cell line by mdr1 antisense oligodeoxynucleotides. Cucco C, Calabretta B. Cancer Res; 1996 Oct 01; 56(19):4332-7. PubMed ID: 8813118 [Abstract] [Full Text] [Related] Page: [Next] [New Search]